Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Objective: To summarize the literature investigating changes in emotional expression (EE) as a function of pharmacotherapy in the treatment of ADHD and to differentiate emotional effects related to ADHD pharmacotherapy from emotional effects related to ADHD as a disorder. Method: English language articles published from January 1, 1988, through August 31, 2008 were identified through a PubMed literature search using the search terms attention, ADHD, hyperactive, hyperkinesis, and ADD cross-referenced with medication terms amphetamine, lisdexamfetamine, methylphenidate , guanfacine, atomoxetine, and clonidine. The search was limited to randomized, controlled trials. Abstracts from all identified articles were selected for further review if they met criteria including (a) presence of a placebo arm, (b) children ≤18 years of age, (c) ≥20 participants, and (b) study design elements that would allow reviewers to determine whether EE phenomena were specifically attributable to medication effects versus alternative explanations (e.g., time, maturation, baseline comorbidity, selection artifacts, or treatments other than the medication-placebo contrast). Qualifying full-text articles were reviewed for prespecified EE terms. Results: Of 148 articles that met selection criteria, 47 reported varying types of EE. Eight of these included two active treatment arms. Hence, 55 data sets were identified. Patterns of change in EE in studies meeting search criteria are discussed. Data sets that reported accounts of EE by the percentage of patients were compiled and further analyzed for specific medication classes. The changes in EE are further discussed as (a) salutary or detrimental, (b) associated with time of day or circumscribed, and (c) presumed to be caused by pharmacological effects. Conclusions: Definitive methodologies for assessing the presence of changes in EE in clinical trials and guidelines for the evaluation of EE in clinical practice are yet to be established and are needed. Such guidelines could be used by clinicians to monitor positive and negative changes in emotion when patients are taking medications for their ADHD. (J. of Att. Dis. 2011; 15(2) 101-112)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, two randomized controlled trials comparing amphetamine against placebo found no beneficial medication impact on a broad range of emotional problems and some studies find amphetamine preparations increase irritability and lability (116).”
From Emotion Dysregulation in Attention Deficit Hyperactivity Disorder (2014) · cites this paper as [116]
In the citing paper
“definitive methodologies for assessing EL changes in practice and clinical trials are as yet unestablished (Manos et al., 2011)”
From A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials (2024) · cites this paper as Manos et al., 2011
Citations
Cites
Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599 · cited 5×
“…Manos, Short, & Findling, 1999; Matza et al., 2004; Mayes, Crites, Bixler, Humphrey, & Mattison, 1994; McCracken et al., 2003; McGough et al., 2005; Michelson et al., 2002; Newcorn et al., 2008; Newcorn, Spencer, Biederman, Milton, & Michelson, 2005; Pelham, Aronoff, et al., 1999; Pelham et al.,…”
BackgroundInfluentialKelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · cited 3×
“…Findling, & Swanson, 2002; Grizenko, Shayan, Polotskaia, Ter-Stepanian, & Joober, 2008; Hinshaw, Buhrmester, & Heller, 1989; James et al., 2001; Kelsey et al., 2004; Klorman, Brumaghim, Fitzpatrick, Borgstedt, & Strauss, 1994; Kratochvil et al., 2007; Manos, Short, & Findling, 1999; Matza et…”
BackgroundBarkley, R. A., McMurray, M. B., EDELBROCK, C. S., & Robbins, K. (1990) · PubMed · Cited by 433
Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics · doi:10.1016/s0149-2918(07)80083-x · Cited by 404
Self-citationBarkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990) · Pediatrics · doi:10.1542/peds.86.2.184 · Cited by 372
Biederman, J., Boellner, S. W., Childress, A., Lopez, F. A., Krishnan, S., & Zhang, Y. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.015 · Cited by 360
Self-citationGillberg, C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210105014 · Cited by 340 · cited 8×
“Three (Ahmann et al., 1993; Gillberg et al., 1997; Short et al., 2004) of these six studies reported EE as a percentage Table 1.”
BackgroundMethodInfluentialNewcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., Michelson, D., & Atomoxetine/Methylphenidate Comparative Study Group (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05091676 · Cited by 336 · cited 5×
“…Wigal, et al., 2004, 2006) reported EE in some manner and eight studies (Biederman, Boellner, et al., 2007; Daviss et al., 2008; Manos et al., 1999; Newcorn et al., 2008; Pelham, Aronoff, et al., 1999; Pelham et al., 1990; Pelham, Gnagy, et al., 1999; Pliszka et al., 2000) had two active…”
InfluentialBiederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317 · cited 3×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine…”
BackgroundInfluentialPelham, W. E., Greenslade, K. E., Vodde-Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M. D., & Dahl, R. E. (1990) · Pediatrics · doi:10.1542/peds.86.2.226 · Cited by 249 · cited 17×
“…2005; Pelham, Aronoff, et al., 1999) — — +4.8% (Barkley et al., 1990; Daviss et al., 2008; Greenhill et al., 2002; Pelham, BurrowsMaclean et al., 2005; Pelham et al., 1990; Pelham, Manos, et al., 2005; Short et al., 2004) +8.0% (Chacko et al., 2005; Pelham, Aronoff, et al., 1999) Socially…”
BackgroundInfluential
Research works printed but not linked: 3
- Grizenko, N., 2008, Journal of Psychiatry & Neuroscience, 33, 10
- 10.1037/0021-843x.103.2.206 · DOI
- 10.1037/0022-006x.57.4.545 · doi:10.1037/0022-006x.57.4.545 · Paper page
Cited by
Emotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070966 · Cited by 1,232
“A review found that two randomized placebo-controlled studies in children with ADHD reported that psychostimulants reduced emotional lability and irritability (127).”
Stringaris, A., Vidal‐Ribas, P., Brotman, M. A., & Leibenluft, E. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12823 · Cited by 220
“There is also evidence against the notion that stimulants increase irritability as a side effect (Ahmann et al., 1993; Manos et al., 2011).”
BackgroundFernández de la Cruz, L., Simonoff, E., McGough, J. J., Halperin, J. M., Arnold, L. E., & Stringaris, A. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.006 · Cited by 120
“Two randomized controlled trials comparing amphetamine and placebo found no beneficial effect of the medication on a broad range of emotional problems, and some studies have found that amphetamine preparations increase irritability and lability.(21) On the other hand, it has recently been shown that children with ADHD…”
BackgroundThe Relation of Poor Emotional Awareness and Externalizing Behavior Among Children With ADHD
Factor, P. I., Rosen, P. J., & Reyes, R. A. (2016) · Journal of Attention Disorders · doi:10.1177/1087054713494005 · Cited by 80
“The child’s age, gender, ADHD subtype, and the presence or absence of psychotropic medication were all entered into the first step as covariates; all of these factors have been found to influence emotional expressiveness (Manos et al., 2011).”
BackgroundReimherr, F. W., Marchant, B. K., Gift, T. E., Steans, T. A., & Wender, P. H. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0176-z · Cited by 63
“While the literature broadly supports the importance of emotional symptoms in ADHD, two recent reviews note the absence of consensus as to how emotional dysregulation in ADHD should be defined and how it should be measured (Manos et al. 2011; Shaw et al. 2014).”
Background
Metadata
- Authors
- Manos, M. J., Brams, M., Childress, A. C., Findling, R. L., López, F. A., & Jensen, P. S.
- Affiliations
- Cleveland Clinic (US)
- Baylor College of Medicine (US)
- Center for Psychiatry and Behavioral Medicine (US)
- University Hospitals Cleveland Medical Center (US)
- Children's Developmental Center, Winter Park, FL
- The REACH Institute, New York, NY
- Corresponding author
- Manos, Michael J.
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2010-09-28
- Volume
- 15
- Issue
- 2
- Pages
- 101-112
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W2042804959
- Cited by
- 28
- References
- 49
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Attention Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- attention deficit hyperactivity disorder, ADHD medication, emotional expression, amphetamine, lisdexamfetamine, methylphenidate, guanfacine, atomoxetine, clonidine, children, emotion monitoring
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Emotions, Humans, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review. https://app.cochat.ai/papers/10.1177/1087054710381230
- The paper
- Manos, M. J., Brams, M., Childress, A. C., Findling, R. L., López, F. A., & Jensen, P. S. (2011). Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review. Journal of Attention Disorders. https://doi.org/10.1177/1087054710381230
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.